In the media 26 Mar 2026 Un golpe de efecto para acabar con la enfermedad del sueño: “Aspiramos a eliminar el trastorno en 2030” El Mundo
Stories Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases
Scientific articles 14 Apr 2026 Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis Clinical and Translational Science
In the media 11 Apr 2026 Face à la dengue, la recherche s’active alors que le réchauffement laisse craindre une saison 2026 record Le Monde
Scientific articles 27 Mar 2026 Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review BMJ Public Health
Scientific articles 14 Jan 2026 (Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance The Lancet Microbe
Scientific articles 24 Mar 2026 The burden of eumycetoma in Africa: a neglected fungal disease The Lancet Regional Health – Africa
Statements 23 Mar 2026 DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement
News 20 Feb 2026 DNDi welcomes GHIT support for lead identification of a novel chemical series in the Eisai-led Chagas disease project
News 2 Feb 2026 Message on the passing of Professor Sir Nicholas White from DNDi Board Chair Dr Marie-Paule Kieny and DNDi Executive Director Dr Luis Pizarro
News 30 Jan 2026 Imperial and DNDi strengthen partnership to accelerate treatments for neglected diseases
News 27 Jan 2026 DNDi and APHRC sign MoU to forge strategic alliance to bridge research and capacity enhancement gaps
